Ph3 Chemo w/ or w/o INCB161734 in Previously Untreated KRAS G12D-Mutated Metastatic PDAC
Phase
Phase III Clinical Trial
Condition(s)
Pancreatic Cancer
Trial Number
07522073
Trial Status
OPEN
Study Overview
A Randomized Double-Blind Phase 3 Study of Chemotherapy With orWithout INCB161734 in Previously Untreated KRAS G12D–MutatedMetastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
